Insider · CIK 0001341411

Burbank Jeffrey H

Reports to the SEC for 2 companies · KENNESAW, GA

sec.gov

Transactions

Companies

Filings

CIK

0001341411

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-18	AORTARTIVION, INC.A Award	Director	AAward	+7,576 sh	—	—	61,372
2025-05-22	AORTARTIVION, INC.A Award	Director	AAward	+6,325 sh	—	—	53,796
2024-05-30	AORTARTIVION, INC.A Award	Director	AAward	+6,289 sh	—	—	47,471
2023-06-06	AORTARTIVION, INC.A Award	Director	AAward	+9,709 sh	—	—	41,182
2022-06-01	AORTARTIVION, INC.A Award	Director	AAward	+7,878 sh	$19.04	+$150K	31,473
2021-06-01	AORTARTIVION, INC.A Award	Director	AAward	+4,423 sh	$29.39	+$130K	23,595
2020-06-01	AORTARTIVION, INC.A Award	Director	AAward	+5,667 sh	$22.94	+$130K	19,172
2020-05-05	AORTARTIVION, INC.A Award	Director	AAward	+1,178 sh	—	—	13,505
2019-05-16	AORTARTIVION, INC.A Award	Director	AAward	+4,163 sh	—	—	12,327
2019-02-21	NxStage Medical, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−782K sh	$30.00	−$23.4M	0
2019-02-21	NxStage Medical, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−39.1K sh	—	—	0
2019-02-21	NxStage Medical, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−189K sh	—	—	0
2019-02-21	NxStage Medical, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−175K sh	—	—	0
2019-02-21	NxStage Medical, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−205K sh	—	—	0
2019-02-21	NxStage Medical, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−268K sh	—	—	0
2019-02-21	NxStage Medical, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−150K sh	—	—	0
2019-02-21	NxStage Medical, Inc.Restricted Stock UnitD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−34.9K sh	—	—	0
2018-05-23	AORTARTIVION, INC.A Award	Director	AAward	+4,638 sh	—	—	8,164
2018-03-14	NxStage Medical, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+36.3K sh	$18.59	+$674K	809,685
2018-03-14	NxStage Medical, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−28K sh	$24.05	−$674K	781,646
2018-03-14	NxStage Medical, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−36.3K sh	—	—	0
2018-03-09	NxStage Medical, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+17.5K sh	—	—	778,579
2018-03-09	NxStage Medical, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,167 sh	$24.37	−$126K	773,412
2018-03-09	NxStage Medical, Inc.Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+52.4K sh	—	—	52,392
2018-03-09	NxStage Medical, Inc.Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−17.5K sh	—	—	34,928
2017-10-26	NxStage Medical, Inc.G Gift	Director, Chief Executive Officer	GGift	−178K sh	—	—	761,115
2017-04-20	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,000 sh	$27.28	−$81.8K	939,086
2017-04-19	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,000 sh	$26.65	−$80K	942,086
2017-03-22	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,000 sh	$27.42	−$82.3K	945,086
2017-03-21	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,000 sh	$27.72	−$83.2K	948,086
2017-03-09	NxStage Medical, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	149,567
2017-03-03	NxStage Medical, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+28K sh	—	—	964,271
2017-03-03	NxStage Medical, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−13.2K sh	$28.31	−$373K	951,086
2017-03-03	NxStage Medical, Inc.Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−28K sh	—	—	0
2017-02-23	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$28.97	−$217K	936,249
2017-02-22	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$29.01	−$218K	943,749
2017-02-10	NxStage Medical, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+124K sh	$9.96	+$1.23M	991,516
2017-02-10	NxStage Medical, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3,697 sh	$18.48	+$68.3K	995,213
2017-02-10	NxStage Medical, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,591 sh	$18.59	+$104K	1,000,804
2017-02-10	NxStage Medical, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−49.6K sh	$28.38	−$1.41M	951,249
2017-02-10	NxStage Medical, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−124K sh	—	—	0
2017-02-10	NxStage Medical, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−3,697 sh	—	—	39,062
2017-02-10	NxStage Medical, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,591 sh	—	—	36,273
2017-01-18	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$27.63	−$207K	867,616
2017-01-17	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$27.52	−$206K	875,116
2016-12-14	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$25.68	−$193K	882,616
2016-12-13	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$25.42	−$191K	890,116
2016-11-23	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$24.01	−$180K	897,616
2016-11-22	NxStage Medical, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,500 sh	$25.51	−$191K	905,116
2016-03-09	NxStage Medical, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+268K sh	—	—	268,159

Recent filings

Accepted (ET)
May 204
Burbank Jeffrey H0001628280-26-037001
SEC(opens sec.gov)
May 274
Burbank Jeffrey H0000784199-25-000105
SEC(opens sec.gov)
Jun 34
Burbank Jeffrey H0000784199-24-000195
SEC(opens sec.gov)
Jun 84
Burbank Jeffrey H0000784199-23-000108
SEC(opens sec.gov)
Jun 34
Burbank Jeffrey H0000784199-22-000147
SEC(opens sec.gov)
Jun 24
Burbank Jeffrey H0000784199-21-000171
SEC(opens sec.gov)
Jun 24
Burbank Jeffrey H0000784199-20-000161
SEC(opens sec.gov)
May 64
Burbank Jeffrey H0000784199-20-000107
SEC(opens sec.gov)
May 174
Burbank Jeffrey H0000784199-19-000116
SEC(opens sec.gov)
Feb 254
Burbank Jeffrey H0001246360-19-000767
SEC(opens sec.gov)
May 254
Burbank Jeffrey H0000784199-18-000113
SEC(opens sec.gov)
Mar 164
Burbank Jeffrey H0001246360-18-001143
SEC(opens sec.gov)

Companies

Address

ARTIVION INC 1655 ROBERTS BLVD NW

KENNESAW, GA, 30144